McLaren High Performance Network, LLC
Medicare Shared Savings Program

ACO Name and Location

McLaren High Performance Network, LLC
Previous Names: N/A
2701 Cambridge Court Suite 200
Auburn Hills, MI 48326

ACO Primary Contact

Primary Contact Name

Kim Hamm

Primary Contact Phone Number

800-822-4950

Primary Contact Email Address

kim.hamm@mclaren.org

Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

ADVANCED CARDIOVASCULAR CLINIC PC

Y

ALBERT A. PRZYBYLSKI, D.O, PC

Y

AMMAR GHANEM MD PLLC

Y

Anup Sud MD PC

Y

BARBARA ANN KARMANOS CANCER HOSPITAL

Y

BARBARA ANN KARMANOS CANCER INSTITUTE

Y

BLUE WATER OB & GYN PC

Y

Board of Trustees of Michigan State University

Y

Brenda Rogers-Grays, DO, PC

Y

Capital Area Anesthesia PC

Y

Capital Internal Medicine Associates PC

Y

CARDIOLOGY ASSOC OF PORT HURON

Y

CARDIOLOGY ASSOCIATES OF MICHIGAN, P.C.

Y

CARDIOLOGY CONSULTANTS OF EAST MICHIGAN PLLC

Y

CARDIOLOGY INSTITUTE OF MICHIGAN, PLLC

Y

CARO COMMUNITY HOSPITAL

Y

Charles J Taunt Jr Do Pc

Y

Chest And Sleep Medicine Consultants,Plc

Y

COSMETIC DERMATOLOGY AND VEIN CENTERS OF DOWNRIVER PC

Y

DANIEL R MESKO DO PC

Y

ELK RAPIDS MEDICAL CLINIC, P.C.

Y

Esa M Ali MD PC

Y

FADI SALLOUM MD PC

Y

Family First - Armada PLLC

Y

Foremost Podiatry Pc

Y

FRED WURSTER DO PC

Y

Frederick R Armenti MD PC

Y

FULL SPECTRUM FAMILY MEDICINE PC

Y

Gary E Hosey DPM PC

Y

Gladstone A Payton DO PC

Y

Heart & Vascular Institute of MI PC

Y

HEART RHYTHM CLINIC OF MICHIGAN PC

Y

Hesham E Gayar MD PC

Y

HURON MEMORIAL HOSPITAL

Y

J Wesley Mesko Md Pc

Y

JAPHET JOSEPH, MD PC

Y

John D Arsen DPM Inc

Y

JOHN KETNER

Y

John N Flood Do Pc

Y

K MOHAN MD PC

Y

Kellam & Associates, P. C.

Y

LANSING SURGICAL ASSOCIATES, P.L.L.C.

Y

Lapeer Pediatrics PC

Y

Larkin Family Medicine PLC

Y

Looking Glass Foot & Ankle Pc

Y

LUNG HEALTH CENTER PLLC

Y

Macomb Internal Medicine Pc

Y

MCLAREN BAY REGION

Y

MCLAREN CENTRAL MICHIGAN

Y

MCLAREN FLINT

Y

MCLAREN GREATER LANSING

Y

MCLAREN HEALTH MANAGEMENT GROUP

Y

MCLAREN LAPEER REGION

Y

MCLAREN MACOMB

Y

McLaren Medical Group

Y

McLaren Northern Michigan

Y

MCLAREN OAKLAND

Y

McLaren Port Huron

Y

MCLAREN PRIMARY CARE

Y

MEDPARTNERS PLC

Y

Michael A Kia Do Pc

Y

MICHAEL J MUELLER MD PC

Y

MOUNT PLEASANT MEDICAL ASSOCIATES PLLC

Y

Mt Morris Medical Group Pllc

Y

Najjar Infectious Disease PC

Y

NORTH OAKLAND NORTH MACOMB IMAGING INC

Y

Northeast Surgical Group PC

Y

Northern Michigan Hematology And Oncology

Y

Northern Michigan Medical Management

Y

Northern Michigan Pain Specialists PC

Y

Northpointe OB-GYN PC

Y

Orthopedic Associates of Port Huron PC

Y

Pain Management Centers PC

Y

PARTNERS IN FAMILY MEDICINE, PLLC

Y

Patrick H Noud Md Plc

Y

Petoskey Family Medicine PC

Y

PETOSKEY RADIATION ONCOLOGY PLC

Y

Preecha Supanwanid, Md Pc

Y

PULMONARY & CRITICAL CARE ASSOCIATES PC

Y

Pulmonary & Critical Care Medicine Consultants Pc

Y

Pulmonary Associates PC

Y

RAOUF MIKHAIL

Y

ROBERT J FRANCHI D O P C

Y

ROSTAM ADULT AND PEDIATRIC MEDICINE PLLC

Y

SINGH & ARORA ONCOLOGY HEMATOLOGY P C

Y

Sunil K Kaushal, MD, P.C.

Y

Surgical Consultants PLLC

Y

THE CARDIAC INSTITUTE

Y

THOMAS C HOSEY DPM & ASSOCIATES PC

Y

Total Kidney Care

Y

Vascular Surgery Assoc PC

Y

VITAL CARE HOME MEDICAL EQUIP INC

Y

VITALCARE, INC

Y

WILFREDO RIVERA, M.D., P.C.

Y

ACO governing body:

Member

Member's Voting Power –Expressed as a percentage or number

Membership Type -

ACO Participant Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

McKenna

Michael

Chairman

1

ACO Participant Representative

McLaren Northern Michigan

Ropp

Brad

Vice Chairman

1

ACO Participant Representative

McLaren Greater Lansing

Kendall

Kathy

Secretary

1

Other – Presidetn/CEO, McLaren Integrated HMO Group

N/A

Mazurkiewicz

David

Treasurer

1

ACO Participant Representative

McLaren Macomb

Wentzloff

Gary

Voting Member

1

ACO Participant Representative

McLaren Central Michigan

Ziccardi

Michael

Voting Member

1

ACO Participant Representative

McLaren Flint

Cowsill

Lawrence

Voting Member

1

ACO Participant Representative

McLaren Oakland

Pinelli

David

Voting Member

1

ACO Participant Representative

McLaren Bay Region

Ali

Esa

Voting Member

1

ACO Participant Representative

Esa M Ali MD PC

Hayes

Mary

Voting Member

1

Medicare Beneficiary

N/A

Key ACO clinical and administrative leadership:

Gary Wentzloff

ACO Executive

Michael Ziccardi

Medical Director

Kim Hamm

Compliance Officer

Kim Hamm

Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Quality and Clinical Integration Committee

Sara Liter-Kuester, D.O., Chair

Utilization Management Committee

Michael Ziccardi, D.O., Chief Medical Officer, Chair

Finance Committee

David Mazurkiewicz,EVP/ CFO, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • First Agreement Period
    • Performance Year 2018, $6,395,854
    • Performance Year 2017, $0

Shared Savings Distribution

  • First Agreement Period
    • Performance Year 2018
      • Proportion invested in infrastructure: 58%
      • Proportion invested in redesigned care processes/resources: 18%
      • Proportion of distribution to ACO participants: 24%
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2018 Quality Performance Results:


ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

80.68

86.14

ACO-2

CAHPS: How Well Your Providers Communicate

91.50

93.93

ACO-3

CAHPS: Patients’ Rating of Provider

90.49

92.45

ACO-4

CAHPS: Access to Specialists

80.69

81.50

ACO-5

CAHPS: Health Promotion and Education

56.26

59.26

ACO-6

CAHPS: Shared Decision Making

59.96

61.94

ACO-7

CAHPS: Health Status/Functional Status

72.91

73.35

ACO-34

CAHPS: Stewardship of Patient Resources

25.10

26.26

ACO-8

Risk Standardized, All Condition Readmission

14.95

14.98

ACO-35

Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)

18.72

18.59

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

40.84

37.01

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

79.26

76.75

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

62.92

59.00

ACO-43

Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91)

1.89

1.98

ACO-11

Use of Certified EHR Technology

99.90

98.20

ACO-12

Medication Reconciliation Post-Discharge

98.10

85.91

ACO-13

Falls: Screening for Future Fall Risk

90.06

79.73

ACO-44

Use of Imaging Studies for Low Back Pain

64.12

64.36

ACO-14

Preventive Care and Screening: Influenza Immunization

68.99

72.71

ACO-15

Pneumonia Vaccination Status for Older Adults

70.23

75.97

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

67.06

76.83

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

81.25

72.81

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

60.73

66.74

ACO-19

Colorectal Cancer Screening

71.03

68.27

ACO-20

Breast Cancer Screening

68.27

71.96

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

79.54

81.47

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

19.50

15.51

ACO-41

Diabetes: Eye Exam

56.74

52.42

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

73.05

73.10

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet

90.67

88.92

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver pursuant to 42 CFR 425.612.
  • No, our ACO clinicians do not provide telehealth services using the flexibilities under 42 CFR 425.612(f) and 42 CFR 425.613.